19(T2)28z1xx TRAC T cell
22-401
Phase 1 mab active
Quick answer
19(T2)28z1xx TRAC T cell for B-Cell Lymphoma is a Phase 1 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- B-Cell Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active